ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Voyageur Pharmaceuticals Ltd

Voyageur Pharmaceuticals Ltd (VM)

0,105
0,035
(50,00%)
Fermé 19 Décembre 10:00PM

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

Dernier
0,105
Prix Achat
0,095
Prix Vente
0,105
Volume échangé
1 942 446
0,07 Fourchette du Jour 0,105
0,04 Plage de 52 semaines 0,105
Cap du marché
Clôture Veille
0,07
Ouverture
0,07
Dernière Transaction
4000
@
0.105
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
105 661
Actions en circulation
132 702 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-9,52
Bénéfice par action (BPA)
-0,01
Chiffre d'affairess
-
Bénéfice net
-1,4M

À propos de Voyageur Pharmaceuticals Ltd

Secteur
Minrls,earths-ground,treated
Industrie
Unit Inv Tr, Closed-end Mgmt
Siège social
Calgary, Alberta, Can
Fondé
2020
Voyageur Pharmaceuticals Ltd est coté dans le secteur Minrls,earths-ground,treated de la TSX Venture Exchange avec le ticker VM. Le dernier cours de clôture d'Voyageur Pharmaceuticals était de $0,07. Au cours de la dernière année, les actions de Voyageur Pharmaceuticals ont été négociées dans une fourchette de prix de $ 0,04 à $ 0,105.

Voyageur Pharmaceuticals compte actuellement 132 702 000 actions en circulation. La capitalisation boursière d'Voyageur Pharmaceuticals est de $9,29 million. Voyageur Pharmaceuticals a un ratio cours/bénéfice (ratio PE) de -9.52.

VM Dernières nouvelles

InvestmentPitch Media Video Discusses Voyageur Pharmaceuticals’ Completed Production of a Test Batch of its SmoothX™ Barium Sulfate CT Contrast Media Oral Suspension for the Canadian CT Imaging Market

VANCOUVER, British Columbia, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Voyageur Pharmaceuticals (TSXV:VM) (OTCPink:VYYRF) has completed production of a test batch of its SmoothX™ barium sulfate CT...

InvestmentPitch Media Video Discusses Voyageur Pharmaceuticals’ Completion of the design of its Carbon Neutral Pharmaceutical Facility and Accelerated Revenue Generation Timeline for its Frances Creek Barium Sulfate Project

VANCOUVER, British Columbia, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Voyageur Pharmaceuticals (TSXV:VM) (OTCPink:VYYRF) has completed the design of its carbon neutral pharmaceutical facility resulting...

InvestmentPitch Media Video Discusses Voyageur Pharmaceuticals’ MOU with Rain Cage Carbon to Develop Fullerene-Based Medical Contrast Agents from Carbon Capture of Hydrocarbon Exhaust Systems

VANCOUVER, British Columbia, Oct. 26, 2022 (GLOBE NEWSWIRE) -- Voyageur Pharmaceuticals (TSXV:VM) (OTCPink:VYYRF) has signed a memorandum of understanding with Rain Cage Carbon to develop...

InvestmentPitch Media Video Discusses Voyageur Pharmaceuticals’ Notice of Work with the BC Ministry of Mines, for the Removal of 2,000 Tonnes of Barium Sulfate from its Frances Creek Project

VANCOUVER, British Columbia, Sept. 23, 2022 (GLOBE NEWSWIRE) -- Voyageur Pharmaceuticals (TSXV:VM) (OTCPink:VYYRF) has submitted a notice of work with the BC Ministry of Mines, for the removal...

Voyageur Secures Exclusive Rights To One Of The Worlds Rarest Pharmaceutical Minerals

  Voyageur Secures Exclusive Rights To One Of The Worlds Rarest Pharmaceutical Minerals, Creating A New Era In Carbon Based Drug Development   Calgary, Alberta: May 11th...

Voyageur Secures Exclusive Rights To One Of The Worlds Rarest Pharmaceutical Minerals, Creating A New Era In Carbon Based Dru...

CALGARY, Alberta, May 11, 2020 (GLOBE NEWSWIRE) -- Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (USA:VYYRF) (the “Company” or “Voyageur”) is pleased to announce it has signed an LOI with an...

Voyageur Restructures its ImagingX Joint Venture

CALGARY, Alberta, March 20, 2020 (GLOBE NEWSWIRE) -- Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (the “Company” or “Voyageur”) is pleased to announce the dissolution of the current joint venture...

Voyageur Pharmaceuticals Announces its “From The Earth To The Bottle” Iodine Contrast Strategy

CALGARY, Alberta, Feb. 26, 2020 (GLOBE NEWSWIRE) -- Voyageur Pharmaceuticals Ltd. (TSX.V:VM, USA:VYYRF) (the “Company” or “Voyageur”) is pleased to announce the fully-integrated iodine business...

Voyageur Pharmaceuticals Implements Frances Creek Environmental Strategy for Bulk Sample and Future Quarry Production

Voyageur Pharmaceuticals Implements Frances Creek Environmental Strategy for Bulk Sample and Future Quarry Production CALGARY, Alberta – The Newswire – February 18th...

Voyageur Pharmaceuticals Implements Frances Creek Environmental Strategy for Bulk Sample and Future Quarry Production

CALGARY, Alberta, Feb. 18, 2020 (GLOBE NEWSWIRE) -- Voyageur Pharmaceuticals Ltd. (TSXV:VM) (the "Company" or "Voyageur") is implementing steps to ensure the Frances Creek barium sulfate project...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.0590.90909090910.0550.1050.0553934610.06998653CS
40.045750.060.1050.0551591800.06836098CS
120.045750.060.1050.051056610.06870415CS
260.0223.52941176470.0850.1050.04797220.06547414CS
520.0551100.050.1050.04797560.06934115CS
1560.03400.0750.20.035881440.08970556CS
2600.03400.0750.350.035982780.10861336CS

VM - Frequently Asked Questions (FAQ)

What is the current Voyageur Pharmaceuticals share price?
The current share price of Voyageur Pharmaceuticals is $ 0,105
How many Voyageur Pharmaceuticals shares are in issue?
Voyageur Pharmaceuticals has 132 702 000 shares in issue
What is the market cap of Voyageur Pharmaceuticals?
The market capitalisation of Voyageur Pharmaceuticals is CAD 9,29M
What is the 1 year trading range for Voyageur Pharmaceuticals share price?
Voyageur Pharmaceuticals has traded in the range of $ 0,04 to $ 0,105 during the past year
What is the PE ratio of Voyageur Pharmaceuticals?
The price to earnings ratio of Voyageur Pharmaceuticals is -9,52
What is the reporting currency for Voyageur Pharmaceuticals?
Voyageur Pharmaceuticals reports financial results in CAD
What is the latest annual profit for Voyageur Pharmaceuticals?
The latest annual profit of Voyageur Pharmaceuticals is CAD -1,4M
What is the registered address of Voyageur Pharmaceuticals?
The registered address for Voyageur Pharmaceuticals is SUITE 800, 333 7TH AVENUE SW, CALGARY, ALBERTA, T2P 2Z1
What is the Voyageur Pharmaceuticals website address?
The website address for Voyageur Pharmaceuticals is www.voyageurpharmaceuticals.ca
Which industry sector does Voyageur Pharmaceuticals operate in?
Voyageur Pharmaceuticals operates in the UNIT INV TR, CLOSED-END MGMT sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
OEG.HONEnergy Inc
$ 0,085
(1 600,00%)
45,54k
DMDataMetrex AI Limited
$ 0,01
(100,00%)
227,13k
NIKL.HGK Resources LTD
$ 0,09
(100,00%)
26,8k
TVC.HThree Valley Copper Corp
$ 0,01
(100,00%)
1,9k
RCTRochester Resources Ltd
$ 0,025
(66,67%)
10k
AAAJ.PAAJ Capital 3 Corp
$ 0,035
(-58,82%)
50k
CHSComprehensive Healthcare Systems Inc
$ 0,005
(-50,00%)
1M
ETUE2gold Inc
$ 0,005
(-50,00%)
10k
ALTAlturas Minerals Corp
$ 0,005
(-50,00%)
10k
BOCABocana Resources Corp
$ 0,005
(-50,00%)
38,86k
THRMTherma Bright Inc
$ 0,03
(20,00%)
8,98M
QNCQuantum Emotion Corp
$ 0,44
(-35,29%)
8,08M
GPUSAlset AI Ventures Inc
$ 0,11
(15,79%)
7,56M
MATEBlockmate Ventures Inc
$ 0,225
(-21,05%)
7,4M
SPCSPC Nickel Corp
$ 0,02
(0,00%)
4,15M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock